CVS Health Corporation $CVS Position Trimmed by Triglav Investments D.O.O.

Triglav Investments D.O.O. trimmed its stake in CVS Health Corporation (NYSE:CVS) by 7.7% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 149,150 shares of the pharmacy operator’s stock after selling 12,415 shares during the quarter. CVS Health accounts for 0.7% of Triglav Investments D.O.O.’s portfolio, making the stock its 27th largest position. Triglav Investments D.O.O.’s holdings in CVS Health were worth $10,288,000 as of its most recent SEC filing.

Other large investors have also recently added to or reduced their stakes in the company. DAVENPORT & Co LLC increased its stake in shares of CVS Health by 3.5% in the first quarter. DAVENPORT & Co LLC now owns 44,120 shares of the pharmacy operator’s stock worth $2,987,000 after acquiring an additional 1,501 shares during the last quarter. First Horizon Advisors Inc. grew its stake in CVS Health by 36.4% in the first quarter. First Horizon Advisors Inc. now owns 9,415 shares of the pharmacy operator’s stock valued at $638,000 after purchasing an additional 2,513 shares in the last quarter. Teacher Retirement System of Texas increased its position in CVS Health by 248.0% in the 1st quarter. Teacher Retirement System of Texas now owns 282,232 shares of the pharmacy operator’s stock worth $19,121,000 after purchasing an additional 201,120 shares during the last quarter. Resonant Capital Advisors LLC acquired a new stake in shares of CVS Health during the 1st quarter valued at about $207,000. Finally, Principal Financial Group Inc. grew its stake in shares of CVS Health by 2.1% in the 1st quarter. Principal Financial Group Inc. now owns 1,452,700 shares of the pharmacy operator’s stock valued at $98,420,000 after buying an additional 29,278 shares in the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

CVS has been the subject of a number of analyst reports. The Goldman Sachs Group assumed coverage on shares of CVS Health in a research note on Tuesday, October 14th. They issued a “buy” rating and a $91.00 target price for the company. Royal Bank Of Canada upped their price objective on shares of CVS Health from $81.00 to $93.00 and gave the stock an “outperform” rating in a report on Thursday. Raymond James Financial raised their target price on CVS Health from $75.00 to $90.00 in a report on Friday. Baird R W upgraded CVS Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, August 14th. Finally, Wolfe Research raised their price objective on CVS Health from $80.00 to $85.00 and gave the company an “outperform” rating in a research note on Monday, September 22nd. Two research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $87.64.

Insider Activity at CVS Health

In related news, Director Anne A. Finucane sold 7,500 shares of the company’s stock in a transaction on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the completion of the transaction, the director directly owned 22,156 shares in the company, valued at approximately $1,573,519.12. This represents a 25.29% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 1.22% of the company’s stock.

CVS Health Trading Up 1.9%

CVS Health stock opened at $78.13 on Friday. The business’s 50-day simple moving average is $76.49 and its 200-day simple moving average is $69.04. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $85.15. The firm has a market capitalization of $99.18 billion, a PE ratio of 205.61, a PEG ratio of 0.87 and a beta of 0.60. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.62 and a current ratio of 0.83.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping the consensus estimate of $1.36 by $0.24. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The company had revenue of $102.87 billion for the quarter, compared to the consensus estimate of $98.85 billion. During the same period in the previous year, the business posted $1.09 EPS. The company’s revenue for the quarter was up 7.8% on a year-over-year basis. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Equities research analysts forecast that CVS Health Corporation will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Stockholders of record on Thursday, October 23rd will be issued a dividend of $0.665 per share. The ex-dividend date is Thursday, October 23rd. This represents a $2.66 annualized dividend and a dividend yield of 3.4%. CVS Health’s payout ratio is presently 700.00%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.